These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23159356)

  • 21. Role of Foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma.
    Mathai AM; Kapadia MJ; Alexander J; Kernochan LE; Swanson PE; Yeh MM
    Am J Surg Pathol; 2012 Jul; 36(7):980-6. PubMed ID: 22446942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance.
    Qiu DM; Wang GL; Chen L; Xu YY; He S; Cao XL; Qin J; Zhou JM; Zhang YX; E Q
    BMC Cancer; 2014 May; 14():327. PubMed ID: 24885292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
    Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
    J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma.
    Wang B; Xu T; Liu J; Zang S; Gao L; Huang A
    Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of somatostatin receptor 2 and 5 expression in operable hepatocellular carcinomas.
    Li S; Liu Y; Shen Z
    Hepatogastroenterology; 2012 Oct; 59(119):2054-8. PubMed ID: 22640914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinoma.
    Wang L; Yao M; Fang M; Zheng WJ; Dong ZZ; Pan LH; Zhang HJ; Yao DF
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):227-232. PubMed ID: 29709351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma.
    Hu S; Wu X; Zhou B; Xu Z; Qin J; Lu H; Lv L; Gao Y; Deng L; Yin J; Li G
    J Cancer Res Clin Oncol; 2014 Jun; 140(6):883-93. PubMed ID: 24647926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythropoietin and erythropoietin receptor in hepatocellular carcinoma: correlation with vasculogenic mimicry and poor prognosis.
    Yang Z; Sun B; Zhao X; Shao B; An J; Gu Q; Wang Y; Dong X; Zhang Y; Qiu Z
    Int J Clin Exp Pathol; 2015; 8(4):4033-43. PubMed ID: 26097591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma.
    Li SX; Tang GS; Zhou DX; Pan YF; Tan YX; Zhang J; Zhang B; Ding ZW; Liu LJ; Jiang TY; Hu HP; Dong LW; Wang HY
    Cancer; 2014 May; 120(10):1520-31. PubMed ID: 24863391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases.
    Schmitz KJ; Sotiropoulos GC; Baba HA; Schmid KW; Müller D; Paul A; Auer T; Gamerith G; Loeffler-Ragg J
    Liver Int; 2011 Jul; 31(6):810-6. PubMed ID: 21645211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
    Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
    Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological Implication of Insulin-like Growth Factor-II mRNA-Binding Protein 3 (IMP3) Expression in Gastric Cancer.
    Lee D; Yu EJ; Ham IH; Hur H
    Anticancer Res; 2017 Jan; 37(1):135-142. PubMed ID: 28011483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clear cell carcinomas of the ovary: a mono-institutional study of 73 cases in China with an analysis of the prognostic significance of clinicopathological parameters and IMP3 expression.
    Bi R; Shen X; Zhang W; Cheng Y; Feng Z; Cai X; Yang W
    Diagn Pathol; 2016 Feb; 11():17. PubMed ID: 26837693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
    Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF
    Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical molecular analysis indicates hepatocellular carcinoma subgroups that reflect tumor aggressiveness.
    Tsujikawa H; Masugi Y; Yamazaki K; Itano O; Kitagawa Y; Sakamoto M
    Hum Pathol; 2016 Apr; 50():24-33. PubMed ID: 26997435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic implication of NQO1 overexpression in hepatocellular carcinoma.
    Lin L; Sun J; Tan Y; Li Z; Kong F; Shen Y; Liu C; Chen L
    Hum Pathol; 2017 Nov; 69():31-37. PubMed ID: 28964792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of MTA2 and Ki-67 in hepatocellular carcinoma and their correlation with prognosis.
    Shi W; Hu J; Zhu S; Shen X; Zhang X; Yang C; Gao H; Zhang H
    Int J Clin Exp Pathol; 2015; 8(10):13083-9. PubMed ID: 26722504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.